by Nutraceutical Ingredients Market size is expected to grow Usd 225.7 bn by 2027 at a CAGR of 7.3% over the forecast period 2020 – 2027.
A new study on the global Nutraceutical Ingredients market has been published by Precedence Research. It presents a wealth of information on key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the global Nutraceutical Ingredients market. The study offers valuable information about the global Nutraceutical Ingredients market to illustrate how the market would grow during the forecast period 2020-2027. The report provides the value and volume of the global Nutraceutical Ingredients market for the period 2020–2027, considering 2019 as the base year and 2027 as the forecast year. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study.
Key indicators of market growth, which include value chain as well as supply chain analyses, and Compound Annual Growth Rate (CAGR), are elucidated in the study in a comprehensive manner. This data can help readers interpret quantitative growth aspects of the global Nutraceutical Ingredients market during the forecast period.
Get the Sample Pages of Report@ https://www.precedenceresearch.com/sample/1162
An extensive analysis on business strategies of leading market players is also featured in study on the global Nutraceutical Ingredients market. This can help readers understand principal factors to foresee growth in the global Nutraceutical Ingredients market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the global market, which is expected to guide market players in making apt decisions in the future.
The report also delves into the competition landscape of the global Nutraceutical Ingredients market. Key players operating in the global market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global market report.
Key Players
- Kraft Heinz Company
- GlaxoSmithKline
- Amway
- Abbott
- Kellogg’s
- Danone
- Cargill Inc.,
- Nestle
- Archer Daniels Midland
- DSM
- BASF
- PepsiCo
- General Mills
- Aker Biomarine
- Procter & Gamble
- Johnson & Johnson
Key Questions Answered in Nutraceutical Ingredients Market Study
– What are the key factors influencing the Nutraceutical Ingredients market in each region?
– What will be the CAGR of the global Nutraceutical Ingredients market between 2016 and 2027?
– What is the future scope and changing trends in technologies in the global Nutraceutical Ingredients market?
– Which factors will impede the growth of the global Nutraceutical Ingredients market during the forecast period?
– Which are the leading companies in the global Nutraceutical Ingredients market?
– Which region is set to expand at the fastest CAGR during the forecast period?
– What is the volume (Units) of different Nutraceutical Ingredients across all regions during the forecast period?
– Which segment will have the highest revenue globally in 2027 and which segment will expand at the fastest CAGR during the forecast period?
Get Customization on this Research Report@ https://www.precedenceresearch.com/customization/1162
Research Methodology
A unique research methodology has been utilized by precedence research to conduct a comprehensive research on the growth of the global Nutraceutical Ingredients market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred to by analysts during the production of the global Nutraceutical Ingredients market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from Nutraceutical Ingredients industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in making precedence research estimates on the future prospects of the global market more reliable and accurate.
Segmentation
By Type
- Probiotic
- Proteins and amino acids
- Phytochemical & plant extracts
- Fibers & specialty carbohydrates
- Omega 3 fatty acids
- Vitamins
- Prebiotic
- Carotenoids
- Minerals
- Others
By Application
- Food
- Beverages
- Personal care
- Animal nutrition
- Dietary supplements
By Health Benefits
- Cognitive health
- Gut health
- Heart health
- Bone health
- Immunity
- Nutrition
- Weigh management
- Others
By Form
- Dry
- liquid
By Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Nutraceutical Ingredients Market, By Product
7.1. Nutraceutical Ingredients Market, by Product Type, 2020-2027
7.1.1. Probiotic
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Proteins and amino acids
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Phytochemical & plant extracts
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Fibers & specialty carbohydrates
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Omega 3 fatty acids
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Vitamins
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Prebiotic
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. Carotenoids
7.1.8.1. Market Revenue and Forecast (2016-2027)
7.1.9. Minerals
7.1.9.1. Market Revenue and Forecast (2016-2027)
7.1.10. Others
7.1.10.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Nutraceutical Ingredients Market, By Application
8.1. Nutraceutical Ingredients Market, by Application, 2020-2027
8.1.1. Food
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Beverages
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Personal care
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Animal nutrition
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Dietary supplements
8.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Nutraceutical Ingredients Market, By Health Benefits
9.1. Nutraceutical Ingredients Market, by Health Benefits, 2020-2027
9.1.1. Cognitive health
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Gut health
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Heart health
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Bone health
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Immunity
9.1.5.1. Market Revenue and Forecast (2016-2027)
9.1.6. Nutrition
9.1.6.1. Market Revenue and Forecast (2016-2027)
9.1.7. Weigh management
9.1.7.1. Market Revenue and Forecast (2016-2027)
9.1.8. Others
9.1.8.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Nutraceutical Ingredients Market, By Form
10.1. Nutraceutical Ingredients Market, by Form, 2020-2027
10.1.1. Dry
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Liquid
10.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 11. Global Nutraceutical Ingredients Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.2. Market Revenue and Forecast, by Application (2016-2027)
11.1.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.1.4. Market Revenue and Forecast, by Form (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.5.2. Market Revenue and Forecast, by Application (2016-2027)
11.1.5.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.1.5.4. Market Revenue and Forecast, by Form (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.1.6.2. Market Revenue and Forecast, by Application (2016-2027)
11.1.6.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.1.6.4. Market Revenue and Forecast, by Form (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.2. Market Revenue and Forecast, by Application (2016-2027)
11.2.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.2.4. Market Revenue and Forecast, by Form (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
11.2.5.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.2.5.4. Market Revenue and Forecast, by Form (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
11.2.6.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.2.6.4. Market Revenue and Forecast, by Form (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.7.2. Market Revenue and Forecast, by Application (2016-2027)
11.2.7.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.2.7.4. Market Revenue and Forecast, by Form (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.2.8.2. Market Revenue and Forecast, by Application (2016-2027)
11.2.8.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.2.8.4. Market Revenue and Forecast, by Form (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.2. Market Revenue and Forecast, by Application (2016-2027)
11.3.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.3.4. Market Revenue and Forecast, by Form (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
11.3.5.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.3.5.4. Market Revenue and Forecast, by Form (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
11.3.6.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.3.6.4. Market Revenue and Forecast, by Form (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.7.2. Market Revenue and Forecast, by Application (2016-2027)
11.3.7.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.3.7.4. Market Revenue and Forecast, by Form (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.3.8.2. Market Revenue and Forecast, by Application (2016-2027)
11.3.8.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.3.8.4. Market Revenue and Forecast, by Form (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.2. Market Revenue and Forecast, by Application (2016-2027)
11.4.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.4.4. Market Revenue and Forecast, by Form (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
11.4.5.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.4.5.4. Market Revenue and Forecast, by Form (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
11.4.6.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.4.6.4. Market Revenue and Forecast, by Form (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.7.2. Market Revenue and Forecast, by Application (2016-2027)
11.4.7.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.4.7.4. Market Revenue and Forecast, by Form (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2016-2027)
11.4.8.2. Market Revenue and Forecast, by Application (2016-2027)
11.4.8.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.4.8.4. Market Revenue and Forecast, by Form (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.2. Market Revenue and Forecast, by Application (2016-2027)
11.5.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.5.4. Market Revenue and Forecast, by Form (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.5.2. Market Revenue and Forecast, by Application (2016-2027)
11.5.5.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.5.5.4. Market Revenue and Forecast, by Form (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2016-2027)
11.5.6.2. Market Revenue and Forecast, by Application (2016-2027)
11.5.6.3. Market Revenue and Forecast, by Health Benefits (2016-2027)
11.5.6.4. Market Revenue and Forecast, by Form (2016-2027)
Chapter 12. Company Profiles
12.1. Kraft Heinz Company
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GlaxoSmithKline
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Amway
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Abbott
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Kellogg’s
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Danone
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Cargill Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Nestle
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Archer Daniels Midland
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. DSM
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. BASF
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. General Mills
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. Aker Biomarine
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. Procter & Gamble
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
12.15. Johnson & Johnson
12.15.1. Company Overview
12.15.2. Product Offerings
12.15.3. Financial Performance
12.15.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Get Full Access of this Research Report, Click here@ https://www.precedenceresearch.com/checkout/1162
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
